Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
26.20
+0.01 (0.04%)
At close: Apr 18, 2025, 2:57 PM CST
SHE:301089 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Jan '20 Jan 1, 2020 | 2015 - 2019 |
Cash & Equivalents | 207.43 | 148.55 | 307.09 | 284.22 | 158.22 | 103.76 | Upgrade
|
Trading Asset Securities | 150.24 | 190.7 | 240.16 | 220.62 | - | - | Upgrade
|
Cash & Short-Term Investments | 357.67 | 339.26 | 547.25 | 504.84 | 158.22 | 103.76 | Upgrade
|
Cash Growth | 1.66% | -38.01% | 8.40% | 219.08% | 52.49% | -40.74% | Upgrade
|
Accounts Receivable | 153.58 | 235.3 | 205.41 | 103.58 | 92.11 | 60.42 | Upgrade
|
Other Receivables | 0.15 | 12.57 | 13.66 | 0.62 | 0.28 | 2.41 | Upgrade
|
Receivables | 153.73 | 247.86 | 219.07 | 104.2 | 92.39 | 62.84 | Upgrade
|
Inventory | 162.79 | 204.11 | 241.14 | 167.08 | 159.9 | 130.93 | Upgrade
|
Other Current Assets | 24.13 | 30.94 | 6.54 | 20.64 | 4.41 | 12.77 | Upgrade
|
Total Current Assets | 698.32 | 822.17 | 1,014 | 796.76 | 414.91 | 310.29 | Upgrade
|
Property, Plant & Equipment | 828.36 | 809.38 | 610.26 | 449.11 | 415.14 | 302.74 | Upgrade
|
Long-Term Investments | 8.97 | 8.37 | 10.86 | 12.54 | 15.62 | 21.83 | Upgrade
|
Other Intangible Assets | 81.29 | 84.04 | 84.26 | 84.56 | 71.02 | 73.04 | Upgrade
|
Long-Term Accounts Receivable | - | - | - | - | - | 3.09 | Upgrade
|
Long-Term Deferred Tax Assets | 71.42 | 63.71 | 70.36 | 6.51 | 7.66 | 7.95 | Upgrade
|
Long-Term Deferred Charges | 2.68 | 2.7 | 1.86 | 2.33 | 8.01 | 4.08 | Upgrade
|
Other Long-Term Assets | 55.55 | 48.62 | 51.64 | 41.9 | 14.11 | 16.83 | Upgrade
|
Total Assets | 1,747 | 1,839 | 1,843 | 1,394 | 946.48 | 739.85 | Upgrade
|
Accounts Payable | 114.64 | 152.55 | 158.58 | 162.94 | 213.38 | 137.58 | Upgrade
|
Accrued Expenses | 8.35 | 24.58 | 69.09 | 17.51 | 21.08 | 16.25 | Upgrade
|
Short-Term Debt | - | - | 40.03 | 64.5 | 147.41 | 133.07 | Upgrade
|
Current Portion of Leases | - | - | - | 4.91 | 18.44 | 19.92 | Upgrade
|
Current Income Taxes Payable | 2.8 | 0 | 66.05 | 1.31 | 2.37 | 0.05 | Upgrade
|
Current Unearned Revenue | 0.85 | 5.48 | 71.89 | 2.9 | 15.66 | 4.74 | Upgrade
|
Other Current Liabilities | 11.81 | 11.9 | 18.32 | 0.53 | 2.15 | 10.47 | Upgrade
|
Total Current Liabilities | 138.45 | 194.51 | 423.96 | 254.6 | 420.5 | 322.08 | Upgrade
|
Long-Term Debt | - | - | - | - | 4.8 | - | Upgrade
|
Long-Term Leases | - | - | - | - | 4.91 | 23.34 | Upgrade
|
Long-Term Unearned Revenue | 33.75 | 35.17 | 38.31 | 40.4 | 23.57 | 7.75 | Upgrade
|
Long-Term Deferred Tax Liabilities | 5.41 | 6.04 | 4.61 | 1.36 | 1.83 | 3.02 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | - | 0.55 | Upgrade
|
Total Liabilities | 177.61 | 235.72 | 466.89 | 296.35 | 455.61 | 356.74 | Upgrade
|
Common Stock | 126.54 | 126.54 | 126 | 126 | 94.5 | 94.5 | Upgrade
|
Additional Paid-In Capital | 621.11 | 621.11 | 585.3 | 578.54 | 66.77 | 66.77 | Upgrade
|
Retained Earnings | 819.89 | 854.18 | 661.5 | 387.57 | 321.86 | 209.06 | Upgrade
|
Comprehensive Income & Other | 1.44 | 1.44 | 3.57 | 5.25 | 7.75 | 12.79 | Upgrade
|
Total Common Equity | 1,569 | 1,603 | 1,376 | 1,097 | 490.87 | 383.11 | Upgrade
|
Shareholders' Equity | 1,569 | 1,603 | 1,376 | 1,097 | 490.87 | 383.11 | Upgrade
|
Total Liabilities & Equity | 1,747 | 1,839 | 1,843 | 1,394 | 946.48 | 739.85 | Upgrade
|
Total Debt | - | - | 40.03 | 69.41 | 175.56 | 176.33 | Upgrade
|
Net Cash (Debt) | 357.67 | 339.26 | 507.22 | 435.43 | -17.34 | -72.57 | Upgrade
|
Net Cash Growth | 1.66% | -33.11% | 16.49% | - | - | - | Upgrade
|
Net Cash Per Share | 2.73 | 2.69 | 4.02 | 4.37 | -0.18 | -0.77 | Upgrade
|
Filing Date Shares Outstanding | 126.54 | 126.54 | 126 | 126 | 94.5 | 94.5 | Upgrade
|
Total Common Shares Outstanding | 126.54 | 126.54 | 126 | 126 | 94.5 | 94.5 | Upgrade
|
Working Capital | 559.87 | 627.66 | 590.04 | 542.16 | -5.59 | -11.78 | Upgrade
|
Book Value Per Share | 12.40 | 12.67 | 10.92 | 8.71 | 5.19 | 4.05 | Upgrade
|
Tangible Book Value | 1,488 | 1,519 | 1,292 | 1,013 | 419.85 | 310.08 | Upgrade
|
Tangible Book Value Per Share | 11.76 | 12.01 | 10.25 | 8.04 | 4.44 | 3.28 | Upgrade
|
Buildings | - | 267.66 | 257.26 | 210.62 | 101.8 | 91.69 | Upgrade
|
Machinery | - | 382.3 | 354.84 | 301.65 | 195.05 | 117.2 | Upgrade
|
Construction In Progress | - | 331.03 | 130.48 | 35.59 | 266.05 | 173.63 | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.